⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL107367 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL11778479 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL11037228 | 0.95 | — | — | |
| SCHEMBL9557740 | 0.84 | — | — | |
| Phosphoramidic Acid SCHEMBL7911730 | 0.82 | CA2 (0.33) | — | |
| Phosphoramidic Acid SCHEMBL15770228 | 0.79 | CA2 (0.50) | — | |
| Phosphoramidic Acid SCHEMBL28814061 | 0.79 | CA2 (0.31) | — | |
| SCHEMBL25522 | 0.78 | — | — | |
| SCHEMBL1685372 | 0.78 | — | — | |
| Phosphoramidic Acid SCHEMBL25846 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230346988-A1 | SYSTEMS FOR IN VIVO MONITORING OF IMMUNE CELLS IN PATIENTS UNDERGOING CELLULAR IMMUNOTHERAPY | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2023-11-02 | — | — | US | disclosed |
| US-20230256121-A1 | DOTA-HAPTEN COMPOSITIONS FOR ANTI-DOTA/ANTI-TUMOR ANTIGEN BISPECIFIC ANTIBODY PRETARGETED RADIOIMMUNOTHERAPY | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2023-08-17 | — | — | US | disclosed |
| EP-2262820-B1 | METHOD FOR THE STEREOSELECTIVE SYNTHESIS OF PHOSPHORUS COMPOUNDS | UNIV HAMBURG (DE) | 2013-06-19 | — | — | EP | disclosed |